Alkem Laboratories Ltd. (Alkem) announced the branding of their active pharmaceutical ingredients (API) business as Alkem Activa, bringing enhanced focus to this growth driver for Alkem. This strategic move underscores the company’s commitment to becoming a formidable global player in the API sector.

Alkem Activa signifies a pivotal move for Alkem Laboratories as the company is dedicated to producing a diverse range of high-quality APIs that cater to the evolving needs of the pharmaceutical industry. Moreover, Alkem Activa reflects Alkem’s focus on sustainability and ensures that it remains at the forefront of API innovation through responsible practices.

It is poised to introduce numerous APIs, further bolstering the Alkem's robust portfolio. Additionally, Alkem Activa plans to expand its capacity, incorporating cutting-edge technologies like biocatalytic and continuous manufacturing technologies to consolidate its position in this field.

By forging partnerships and collaborations, Alkem Activa aims to become a reliable supplier of high-quality APIs to pharmaceutical companies worldwide, contributing to the global healthcare ecosystem.

Speaking about the company’s vision, Sandeep Singh - Managing Director of Alkem, said, “Today, we mark a significant chapter in our journey. Alkem Activa represents our renewed commitment to API excellence, innovation, and global outreach. With our tagline, 'Innovative. Reliable. Sustainable,' we signify our determination to propel Alkem Activa into the forefront of the API market with sustainability at the core of our operations.”

“We envision Alkem Activa as a key contributor to healthcare solutions globally,” Sandeep Singh affirmed. “Our aim is to strengthen our position in the API market, enhance accessibility to quality pharmaceutical ingredients, and shape the future of healthcare together with our partners.”

Alkem Activa represents a continuing journey towards affordable, high-quality healthcare solutions for patients worldwide.